Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
- Ifedayo M. O. Adetifa
- Sophie Uyoga
- John N. Gitonga
- Daisy Mugo
- Mark Otiende
- James Nyagwange
- Henry K. Karanja
- James Tuju
- Perpetual Wanjiku
- Rashid Aman
- Mercy Mwangangi
- Patrick Amoth
- Kadondi Kasera
- Wangari Ng’ang’a
- Charles Rombo
- Christine Yegon
- Khamisi Kithi
- Elizabeth Odhiambo
- Thomas Rotich
- Irene Orgut
- Sammy Kihara
- Christian Bottomley
- Eunice W. Kagucia
- Katherine E. Gallagher
- Anthony Etyang
- Shirine Voller
- Teresa Lambe
- Daniel Wright
- Edwine Barasa
- Benjamin Tsofa
- Philip Bejon
- Lynette I. Ochola-Oyier
- Ambrose Agweyu
- J. Anthony G. Scott
- George M. Warimwe
Publication date
June 2021
DOI Publisher
Springer Science and Business Media LLC Journal
Nature CommunicationsAbstract
The reported burden of SARS-CoV-2 has been relatively low in tropical Africa compared to Europe and the Americas, but estimating true infection rates is challenging. Here, the authors screen blood donors in Kenya for SARS-CoV-2 antibodies and describe spatiotemporal seroprevalence dynamics
Add to ORKG